Authors:
Damier, P
Tremblay, L
Feger, J
Hirsch, EC
Citation: P. Damier et al., Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (priming)., REV NEUROL, 156(3), 2000, pp. 224-235
Authors:
Touze, E
Gout, O
Verdier-Taillefer, MH
Lyon-Caen, O
Alperovitch, A
Citation: E. Touze et al., First central nervous system demyelination and hepatitis B vaccination: a pilot case control study., REV NEUROL, 156(3), 2000, pp. 242-246
Authors:
Vernay, D
Gerbaud, L
Biolay, S
Coste, J
Debourse, J
Aufauvre, D
Beneton, C
Colamarino, R
Glanddier, PY
Dordain, G
Clavelou, P
Citation: D. Vernay et al., Quality of life and multiple sclerosis: validation of the French Version of the MSQOF self-questionnaire (sep-59)., REV NEUROL, 156(3), 2000, pp. 247-263
Citation: P. Verstichel et C. Meyrignac, Left unilateral melokinetic apraxia and left dynamic apraxia following partial callosal infarction., REV NEUROL, 156(3), 2000, pp. 274-277
Citation: B. De Toffol et al., Partial motor epilepsy, intracranial hematoma and protein S deficiency in a 49-year-old woman, REV NEUROL, 156(3), 2000, pp. 312-317
Citation: L. Vercueil, Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature., REV NEUROL, 156, 2000, pp. 14-22